title: Private biotech 2004--the numbers.
abstract: Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.
authors.affiliation: Critical I Limited, The Colin Sanders Innovation Centre, Mewburn Road, Banbury, OX16 9PA, UK. john.hodgson@criticali.net
authors.forename: John
authors.initials: J
authors.lastname: Hodgson
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D005060:Europe; D007182:Income / Q000706:statistics & numerical data* / Q000639:trends; D007221:Industry / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D017149:Private Sector / Q000191:economics* / Q000706:statistics & numerical data*; D014481:United States